Changes and clinical significance of the child patients with HFMD serum IL6 IL10 IL17 levels毕.docx
- 文档编号:15876465
- 上传时间:2023-07-08
- 格式:DOCX
- 页数:8
- 大小:19.97KB
Changes and clinical significance of the child patients with HFMD serum IL6 IL10 IL17 levels毕.docx
《Changes and clinical significance of the child patients with HFMD serum IL6 IL10 IL17 levels毕.docx》由会员分享,可在线阅读,更多相关《Changes and clinical significance of the child patients with HFMD serum IL6 IL10 IL17 levels毕.docx(8页珍藏版)》请在冰点文库上搜索。
ChangesandclinicalsignificanceofthechildpatientswithHFMDserumIL6IL10IL17levels毕
ChangesandclinicalsignificanceofthechildpatientswithHFMDserumIL-6?
IL-10?
IL-17levels
HuangXiaoFeiTanWeipingJiangRunchang
[Abstract][Objective]Toexplorethehand,footandmouthdisease(HFMD)inchildrenwithperipheralinterleukin-6(IL-6)?
Interleukin-10(IL-10)?
Interleukin-17(IL-17)levelinHFMDdevelopmentprocessinthechange?
[method]Inthisstudy,usingdoubleantibodysandwichenzyme-linkedimmunosorbentassay(ELISA)methodforthedeterminationof19casesofHFMDinchildren(acutephase?
recovery)andthesameperiodin20healthychildrenserumIL-6?
IL-10?
IL-17content;andHFMDacutephase?
convalescentandhealthychildrenpairwisecomparison,anunderstandingofIL-6?
IL-10?
IL-17changesinthetheHFMDdevelopmentprocess?
[results]?
childpatientswithHFMDacutephaseofIL-6?
IL-10andIL-17levelsweresignificantlyhigherthanthehealthycontrolgroup(P<0.01);convalescentIL-6andIL-17levelsandthecontrolgroupshowednosignificantdifference(P>0.05)?
stillhigherthanthehealthycontrolgroup(P<0.01)andIL-10levels?
?
acutephaseofIL-6andIL-10showedanegativecorrelation(P<0.05);IL-6andIL-17waspositivelycorrelated(P<0.01);IL-10andIL-17showedanegativecorrelation(P<0.05)?
convalescence:
IL-6andIL-10wasnegativelycorrelated(P<0.05);IL-6andIL-17showedapositivecorrelation(P<0.01);correlation(P>0.05)betweenIL-10andIL-17?
[Conclusion]childpatientswithHFMDacuteinflammatorycytokines(IL-6?
IL-17)levelssignificantlyincreasedtheinhibitorycytokineIL-10levelscontinuedintotherecoveryperiod?
[Words]ofhand,footandmouthdiseaseinchildrenwhiteinterleukin
Abstract:
[Objective]Tostudythechangesandclinicalsignificanceofseruminterleukin(IL)-6,IL-10,andIL-17levelsinthechildrenwithhandfootandmouthdisease(HFMD).[Method]TheserumconcentrationofIL-6,IL-10,andIL-17in19casesofHFMDchildren(acutestageandconvalescence)and20casesofhealthycontrolsweremeasuredbyELISA.Thecytokineslevelswerecompared.[Results]1.Comparedwithhealthycontrols,thelevelsofIL-6,IL-10,andIL-17inacutestageofHFMDweresignificantlyincreasedinHFMDchildren(P<0.01).TherewasnosignificantdifferenceofthelevelsofIL-6andIL-17betweentheconvalescenceofHFMDandhealthychildren(P>0.05),HoweverthelevelsofIL-10inconvalescenceofHFMDwerehigherthanhealthychildren(P<0.01).2.SpearmancorrelationanalysisrevealedthatIL-6andIL-17werenegativelycorrelatedwithIL-10(P<0.05);IL-6positivelycorrelatedwithandIL-17inacutestage(P<0.01).InconvalescenceIL-6wasnegativelycorrelatedwithIL-10(P<0.05),positivelycorrelatedwithIL-17(P<0.01);IL-10andIL-17havenocorrelativerelation(P>0.05).[Conclusions]1.ThelevelsofIL-6andIL-17weresignificantlyincreasedinacutestageofHFMDchildren.2.ThepersistentelevationofserumIL-10levelwasfoundinHFMDpatientsafterconvalescence.
Keywords:
:
hand,footandmouthdisease;children;interleukin
Vasculartumorsandvascularmalformationsisacommonclinicaldisease,theclassificationofitscomplexity,thedifferencesinclinicalmanifestations,broughtmanydifficultiestoclinicianschoosethebesttreatmentoptionsinordertobetterunderstandthevasculartumorinsouthernChina?
malformationsofthepatient’ssituation,nowretrospectiveanalysisoftheFirstAffiliatedHospitalclinicaldataof592casesofvasculartumororvascularmalformationinhospitalizedpatients,clinicalpresentation,diagnosis,andtreatmentsummaryanddiscussionofitscharacteristicsofthedisease?
?
1Materialsandmethods
1.1Selectionofcases
ClinicaldatacollectedfromJanuary2006toSeptember2009,theFirstAffiliatedHospitalofSunYat-senUniversityofvasculardiseaseinhospitalizedpatients,whileexcludinglesionsinvolvingtheintracranialorvisceralaswellasduringhospitalizationwerenottreatedcasesget:
hospitalizedpatientsoverthesameperiod856casesselecteddepartmentsincluding:
592cases(involvingvascularsurgery?
OralandMaxillofacialSurgery?
PediatricSurgery?
orthopedics?
dermatology?
plasticsurgery)?
1.2ClassificationofDiseases
Combinationofthepatient’smedicalhistory,physicalexamination,imagingandpathologyresults,withreferencetotheInternationalAssociationfortheStudyofVascularAnomalies(InternationalSocietyfortheStudyofVascularAnomalies,ISSVA)modernclassificationcriteria[1],inourhospitalpathologistguidanceunder,vasculardiseasewerefurtherdividedintovasculartumororvascularmalformationintwocategories?
thevasculartumormicroscopiccharacteristics[1-2]:
endothelialcellhyperplasia,cellswiththecharacteristicsoftheembryonicvascularendothelialendothelialcelldistributionintheformofpelletsorcords,visiblepartofthecellsthenormalmitotic?
malformationsmicroscopiccharacteristics[1-2]:
endothelialflatcellstomature,therearenoorveryfewnormalmitoticfigures,vascularnumbersignificantlyincreasedcomparedwithnormaltissue,andthelumendilatedvascularmalformationstraffic;reducedorlackofpartofthewallofthemiddleoftheelasticfibercomponents,walltensiondecreased,thinning;lesionscanbeindividuallyinvolvedcapillaries?
veins,arteriesorlymphatic,alsoinvolvingavarietyofvasculartype?
1.3Statisticalanalysis
Non-normaldistributionofthedatausingthemedian(Q:
interquartilerange)expression?
UsingSPSS16.0statisticalsoftwaretoanalyzetheresults,thechi-squaretestortheWilcoxonranksumtest,P<0.05DifferenceswereconsideredTherearesignificant?
2Results
2.1Generalclinicaldata
592casesofvasculardisease(M:
F=1:
1.18),vasculartumorsof187cases(31.6%),withamedianageofJuly(Q=9months);vascularmalformationin405cases(68.4%)Themedianagewas17yearsold(Q=21yearsold)?
initialtreatmentofallpatientswithdiseasedurationrangedfrom2weeksto69yearsbefore,themediantimefor1year?
respectivelystatisticsvasculartumorgroupandvascularmalformationsgroupforthefirsttimetreatmentbeforethecourse:
Theformerrangefromtwoweeksto19years,themediantimefromMay;latterrangedfrom1monthto69years,themediantimeforfouryears?
Vasculartumorgroup,theheadandneckisthemostcommon(41.2%)oftheaffectedparts?
Malformationsgroup,lowerextremityofthemostcommon(37.0%)oftheaffectedparts?
Somepatientswithlesionssimultaneouslyaccumulatedtwoormoreparts?
Table1showsthevasculartumorgroupandvascularmalformationsgroupthenumberoflesions?
derivedfromthechi-squaretest:
thetwogroupsshowednosignificantdifference(P>0.05)?
2.2Clinicalmanifestations
Vasculartumorpatientsand30.9%(125/405)ofthe592casesofpatientswithvasculardisease,morethan9%ofpatientsdescribethelesionsinthedevelopmentofthediseaseprocesssignificantlylarger?
8.6%(16/187)ofpatientswithvascularmalformationsThesymptomscausedbythedisease(includinglocalpain,ulceration,bleeding,paresthesia,etc.)?
usingthechi-squaretestdrawn:
theproportionofthedifferencewasstatisticallysignificant(P<0.001)ofthesymptomsinthetwogroups?
2.3lesionsinvolvinglevel
Inadditiontothe35casescannotbedeterminedduetoincompletesurgicalresectionorinformationotherthanlesionsinvolvingthelevelintheremaining557patientswithvasculardisease,themajorityoflesionsinvolvedthetwoormoreoftheorganizationalhierarchy?
Includingsubcutaneoustissueinvolvement422patients(75.8%),muscletissueinvolvementin243cases(43.6%),andskininvolvementin152cases(27.3%),mucosalinvolvementinfourcases(0.7%),boneandjoint(periosteum,marrowcavity,orjoint)involvementin29cases(5.2%)?
involvingmuscleorboneandjointlesionsclassifiedasdeeplesions,otherwiseclassifiedassuperficiallesions?
Table2showsthevasculartumorgroupshadesandvascularmalformationsgrouplesions:
thelatterlesionsinvolvingdeeptissueratio(60.1%)thantheformer(12.3%),chi-squaretestdrawn,thedifferencewasstatisticallysignificant(P<0.001)betweenthetwo?
2.4treatment
Thepresentstudy,thevasculartumorpatientsreceivingtreatmentinclude:
completeresection?
Partialnephrectomy?
Resectioncombinedplasticsurgery?
Theresectionjointhardenersurgery?
Thehardenertherapy?
Embolizationtherapy,lasertherapy?
Malformationspatientsacceptedtreatmentinclude:
completeresection?
partialnephrectomy,ligation,excisioncombinedplasticsurgery?
theexcisionjointhardenersurgery?
thejointresectionembolization?
thehardenertherapy?
Embolization?
lasertherapy?
microwavetherapy?
chemotherapytherapy,cryotherapy?
ordertofurtherunderstandtherelationshipbetweenvasculardiseasetypeselectedtreatment,weselectedsixkindsofprimarytreatment(560cases)statisticsandcustomdividedinto3groups(Table3):
aradicalprogram(completeresection)?
apartialhepatectomyprograms(partialnephrectomy?
embolizationplussurgicalexcision?
surgicalexcision+skingrafting)?
thepalliativeprogramof(simpleligation?
embolizationalone)?
usingtheWilcoxonrankdrawnandinspection:
thedifferencewasstatisticallysignificant(P<0.001)inthevasculartumorgroupandvascularmalformationsgrouptherapy?
2.5intraoperativebloodlossandtransfusion
Linelesionsin592patientswithvasculardisease,552cases(93.2%)resection(resectionincombinationwithothertreatmentmodalities)?
Intraoperativeblood
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- Changes and clinical significance of the child patients with HFMD serum IL6 IL10 IL17 levels毕 levels
链接地址:https://www.bingdoc.com/p-15876465.html